Fab Antivenom Controversy Continues.

Ann Emerg Med

Department of Student Health, University of Virginia, Charlottesville, VA.

Published: December 2017

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annemergmed.2017.08.002DOI Listing

Publication Analysis

Top Keywords

fab antivenom
4
antivenom controversy
4
controversy continues
4
fab
1
controversy
1
continues
1

Similar Publications

The onset, progression, and severity of pain following rattlesnake envenomation are highly variable between patients. Pain can be severe and persistent, seemingly refractory to opioid analgesics. The ability of antivenom to directly relieve pain has not been well studied.

View Article and Find Full Text PDF
Article Synopsis
  • The western pygmy rattlesnake is a small but dangerous snake native to several U.S. states, including Missouri and Tennessee.
  • Bites from this snake can lead to serious health issues like hospitalization and tissue damage.
  • A case study highlights a 56-year-old man who was bitten and required antivenom treatment and prolonged wound care.
View Article and Find Full Text PDF

Evaluation of Antivenom Therapy for Middle East Scorpion Envenomations.

Pediatr Emerg Care

January 2025

Division of Clinical Toxicology, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.

Introduction: Scorpion envenomation is a leading cause of envenomation in our region. Antivenom has been used successfully to treat the systemic manifestations of envenomations inflicted by toxic scorpions. Toxic scorpions common in our area include Leiurus quinquestriatus , Androctonus australis , and Buthus occitanus .

View Article and Find Full Text PDF

Production of an Efficient Enzymatically Fab Fragment Antivenom against Cobra Snake () Venom.

Arch Razi Inst

April 2024

Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.

Since around 100 years ago, the best treatment for millions of global snakebite victims has been polyclonal antivenoms. However, common antivenoms need continuous improvement to reduce rare, their side effects and get better performance. In the present study, Fab antivenom was produced through papain digestion of anti-cobra venom plasma, multi-step purification, and optimization, including ammonium sulfate precipitation and DEAE-cellulose column chromatography.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!